| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | Please See Remarks
2 companies
Mock James M is a Chief Financial Officer at MRNA, with reported holdings spanning 2 companies. Recent filings cover 0 purchases and 26 sales. Those positions are worth an estimated $4.0M at current prices.
Our model assigns Mock James M a strong insider score of 85/100, based on 14 past trades. Over a 12-month horizon, 100.0% of those trades were profitable, with an average 12-month return of +60.2%.
Mock James M's largest disclosed position is in RVTY as Please See Remarks, worth about $4.0M. The recent filings there lean toward selling, a net 16,728 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 10, 2026 | MRNA Moderna, Inc. | Chief Financial Officer | Sale+OE10b5-1 | 34,836 | $134.49 | $4,685,093.64 | -37.0% | - | - | |
| Nov 29, 2024 | MRNA Moderna, Inc. | Chief Financial Officer | Sale+OE10b5-1 | 1,420 | $42.79 | $60,760.52 | -11.4% | -27.8% | -39.7% | |
| Oct 7, 2024 | MRNA Moderna, Inc. | Chief Financial Officer | Sale+OE10b5-1 | 715 | $60.12 | $42,985.80 | -7.0% | -27.5% | -53.4% | |
| Aug 29, 2024 | MRNA Moderna, Inc. | Chief Financial Officer | Sale+OE10b5-1 | 162 | $78.03 | $12,640.21 | -1.8% | -44.1% | -69.0% | |
| Aug 28, 2024 | MRNA Moderna, Inc. | Chief Financial Officer | Sale+OE10b5-1 | 1,321 | $79.39 | $104,880.66 | -13.3% | -46.3% | -68.8% | |
| Jul 8, 2024 | MRNA Moderna, Inc. | Chief Financial Officer | Sale+OE10b5-1 | 689 | $118.24 | $81,465.36 | -8.7% | -49.6% | -72.1% | |
| Jun 3, 2024 | MRNA Moderna, Inc. | Chief Financial Officer | Sale+OE10b5-1 | 691 | $140.72 | $97,237.38 | -9.6% | -50.7% | -81.2% | |
| May 29, 2024 | MRNA Moderna, Inc. | Chief Financial Officer | Sale+OE10b5-1 | 183 | $144.50 | $26,444.36 | -3.0% | -46.6% | -81.8% | |
| May 28, 2024 | MRNA Moderna, Inc. | Chief Financial Officer | Sale+OE10b5-1 | 648 | $162.47 | $105,282.89 | -10.2% | -46.7% | -83.0% | |
| Apr 8, 2024 | MRNA Moderna, Inc. | Chief Financial Officer | Sale+OE10b5-1 | 705 | $101.93 | $71,859.31 | -12.3% | +10.8% | -76.6% |